Trade HaS s.r.o.
Slovakia

mobil: +421 907 794 037
mobil: +421 905 617 208

 e-mail



REBOX CLASSIC
REBOX Physio Classic

Články

Referencie na Internete

Hlavná stránka










(c) Trade HaS s.r.o. 2012
MUDr. I. MARTULIAK, MUDr. L. PREČIANSKÁ
THE CENTER FOR TREATMENT AND RESEARCH OF PAIN
F.D. ROOSEVELT HOSPITAL
BANSKÁ BYSTRICA
REBOX AND ITS USE IN ALGESIOLOGIC PRACTICE

We have worked with REBOX in our outpatient department since May, 1994. The REBOX machine we have used is one of the TENS series (=transcutaneous electrical neural stimulation). This REBOX is superior to other REBOX machines because it includes a wider variety of applications. 
The working principle of REBOX is the influence of modulated direct electrical current from the batteries on the patient s tissue in the form of impulse stimulation. REBOX has a significant ability to gain information from tissue during treatment. This ability enables us to monitor and manage treatment in an ideal manner. The current causes transcutaneous relaxation of the sphincters of arterioles and sympathetic vessels, as well as the relaxation of voluntary and involuntary muscle contractions. The effect itself is due to changes in the concentration of free ions in the extracellular liquid, especially of hydrogen, sodium, potassium, and calcium ions, which are attracted to the active negative electrode laying on the patient s skin. These free ions are thus most eefectively concentrated in the area of injured tissue. REBOX therefore has a most beneficial spasmolytic, vasodilative, and myorelaxant effect on various pathological conditions. Aside from this main program, REBOX also has a program called "analgetic". This program, like the classical TENS program, directly influences the pain impulse path through the nerve and insures a solid temporary analgesia in the injured area. 
The most interesting part of the REBOX evaluation is the treatment indication. REBOX is principally indicated in most benign, non-inflammmatory pains. Contraindications include shock-related conditions, cardiac stimulation, malignant conditions, pregnancy, thrombosis, and inflammatory skin disease. The most frequent conditions treated with REBOX include back pain syndrome, headaches and migraines, post-operational and post-traumatic conditions, epicondilytis, and enthesopathia. With REBOX, one can also successfully treat urinary colic and paralytic constipation conditions. REBOX is also showing promising effect in the treatment of neuralgias, especially of post-herpetic kind. REBOX can also be used for the treatment of perceptual hearing and subjective murmurs, skin scars, lymphatic edemas, contractions connected with multiple sclerosis, ischemic syndromes of lower limbs, etc. 
Over a period of six months, we treated 123 patients (Chart 1) with REBOX in our outpatient department. Sixty of these patients had back pain syndrome (Chart 2). We had comparable success with patients who suffered from headaches, ethesopathia and the so-called "post-puncture headaches". We were less successful with patiens who suffered from hard post-traumatic contractions and chronical lumbosacral pains with disk hernia. 
Patients suffering from mostly post-herpetic neuralgia of the nerve trigeminus and of the intercostal nerves presented an interesting treatment group (Chart 3). It is necessary to mention, however, that all patients were simultaneously treated with homeopathic medications and with analgesics. During the REBOX treatment these medications were gradually omitted. We intend to follow up on this study in greater detail in the future. 
Ordinarily, REBOX is applied three to five times a week. However, one-time application to eliminate the most painful conditions is often sufficient. 

REBOX is user-friendly and easily transportable. Its main advantage, however, is its frequently successful effect on painful 
conditions which often cannot be treated in any other way. REBOX should be present in all locations or hospital departments
where painful conditions are treated. This recommendation is further supported by the references of our colleagues not only
from the Czech Republic, but also from many other locations in Europe and around the world. 

Presented at the "Slovak Dialogues On Pain" in Martin in November, 1994 
 
CHART 1
DISTRIBUTION OF PATIENTS ACCORDING TO THE DIAGNOSIS
(123 patients)
 
DIAGNOSIS NUMBER 
     No.
OF PATIENS 
        %
Back pain syndrome
60
48,8
Neuralgia
11
8,9
Headaches
11
8,9
Enthesopatia
11
8,9
Post-traumatic condition
7
5,7
Disk hernia
4
3,2
Acute cervical syndrome
3
2,4
Acute lumbosacral pains
3
2,4
Post-puncture pains
3
2,4
Reflex sympathetic dystrophy
3
2,4
Paresis of the facial nerve
2
1,6
Other
5
4,1
 
 
CHART 2
EFFECTIVENESS OF REBOX ON PATIENTS WITH BACK PAIN SYNDROME
(60 patients)
 
EFECT NO PROBLEMS
    IMP 
 ++
ROVE 
    +
MENT 
    0
RESULT 
UNKNOWN
NO. of          No. 
patiens          %
30
50
18
30
7
11,8
1
1,6
4
6,6
EVALUATION ----------------------->
  80% 
--------- --------->
20%
Average number of treatement sessions> 3.3 per patient
 
CHART 3
EFFECTIVENESS OF REBOX ON PATIENTS WITH NEURALGIA
OF TRIGEMINUS NERVE AND INTERCOSTAL NERVES
(13 patients)
 
EFECT NO PROBLEMS     IMP 
 ++
ROVE 
    +
MENT 
    0
NO. of          No. 
patiens          %
6
46.2
3
23
2
15.4
2
15.4
EVALUATION ----------------------->
  69.2% 
--------->   28.8 % 
Average number of treatement sessions> 3.3 per patient
USE OF REBOX INT HE PAIN CENTER IN 1995 
(520 patients)
 
Evaluation of the treatment effectiveness: 4 -VRS (Verbal Rating Scale)
I. No problems
II. Significant improvement
III. Mild improvement
IV. No improvement